Open Access Article
Mario
Leypold
*a,
Lorenzo
Poli
a,
Max
Earl
a,
Okky D.
Putra
b,
Karolina
Kwapien
a,
Richard J.
Lewis
a,
John J.
Murphy
a,
Marta
Passamonti
a,
Lena M.
von Sydow
a,
Victor
Spelling
c,
Ioannis
Asproudis
b,
Malvika
Sardana
c,
Claudia
Gatti
d,
Hikaru
Seki
a,
Thomas
Lemaitre
a,
Radvile
Juskaite
a,
Ranganath
Gopalakrishnan
a,
Stuart J.
Francis
a,
Cristina
Gardelli
a,
Per-Ola
Norrby
e and
Werngard
Czechtizky
a
aMedicinal Chemistry, Research and Early Development, Respiratory and Immunology, BioPharmaceuticals R&D AstraZeneca, Pepparedsleden 1, 43183 Mölndal, Sweden. E-mail: mario.leypold@astrazeneca.com
bEarly Product Development and Manufacturing, Pharmaceutical Sciences, R&D AstraZeneca, Pepparedsleden 1, 43183 Mölndal, Sweden
cEarly Chemical Development, Pharmaceutical Sciences, R&D AstraZeneca, Pepparedsleden 1, 43183 Mölndal, Sweden
dEarly Chemical Development, Pharmaceutical Sciences, R&D AstraZeneca, Macclesfield SK10 2NA, UK
ePredictive Science, Digital and Automation, Pharmaceutical Sciences, R&D AstraZeneca, Pepparedsleden 1, 43183 Mölndal, Sweden
First published on 27th May 2026
Correction for ‘Regioselective synthesis of aza-saccharins via anionic [1,4] Fries-type rearrangement of aryl sulfonimidoyl fluorides’ by Mario Leypold et al., Chem. Sci., 2026, https://doi.org/10.1039/d6sc00432f.
The Royal Society of Chemistry apologises for these errors and any consequent inconvenience to authors and readers.
| This journal is © The Royal Society of Chemistry 2026 |